skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreProduct loginProductLogin
Global Search Configuration

​Master the marketplace

master market place pharma intelligence

To succeed in the pharmaceutical marketplace, it’s vital to stay up to date with developments that can affect your business. Our competitive and market intelligence can give you all the credible, detailed information you need in one place.

 

What we offer

You can quickly access referenced information across global key industry developments in the pharmaceutical and medical technology markets with our easy-to-use solutions and expert analysts.

 

Build detailed competitive and market landscape analyses quickly, with access to global information on:

  • Drug and device development
  • Patient populations
  • Clinical trials
  • Drug and device patents
  • Market moving events
  • Patient-based sales forecasts

 

How it helps

We help you more accurately:

  • Prioritize pharmaceutical R&D spend by finding gaps and unmet needs through the analysis of competitors’ targets and R&D priorities
  • Understand disease epidemiology and disease sub-populations targeted in clinical development
  • Anticipate market changes through patent expiration tracking
  • Earmark who is entering or exiting your market via licensing or acquisition, as well as who is securing or providing funding
  • Project revenue for your pipeline and marketed drugs
Contact us

Relevant products

video-thumb-sample

Discover the power of Pharma360

More
video-thumb-sample

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions
More
video-thumb-sample

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

  • Prioritize market opportunities and stay ahead of the competition
  • Identify unmet needs and forecast the future of your market
  • Make informed commercial decisions with insights from the best analysts in the industry
More
View all content

Pharma Intelligence latest insights

  • Scrip

    Deal Watch: How Did J.P. Morgan Deal-Making Compare To Prior Years?

    17 Jan 2022

    Deal_Watch_592000391_1200_675_1200

    Licensing deals and partnerships carried the day during another hectic J.P. Morgan Healthcare Conference. Pfizer racked up its third deal of the week in a cancer collaboration with Dren Bio.

    article

  • Pharma Intelligence Apps

    Not all news services are created equal

    06 Jan 2022

    Not all news services are created equal

    Pharma Insights team of trusted journalists bring you the most critical news and analysis round the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

    report

  • The Decline And Fall Of The Pharma Pipeline

    Alex Shimmings 23 Mar 2017

    The Decline And Fall Of The Pharma Pipeline

    2016 saw a drop in the growth rates for both number of products in active development and in the number of companies in active R&D. The data from a new report from Pharmaprojects seem to point to an end to recent years of accelerated growth in the pipeline that followed five years of stagnation.

    article

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact Sales

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now